Skip to main content
. 2020 Oct 7;15:233. doi: 10.1186/s13014-020-01673-6

Table 1.

Patients’ characteristics

Demographics, n 13
Median age, years (range) 62.2 (33.7–74.0)
Sex, n (%)
 Male 9 (69.2)
 Female 4 (30.8)
Nationality, n (%)
 Lebanese 8 (61.5)
 Iraqi 2 (15.4)
 Jordanian 3 (23.1)
ECOG performance status, n (%)
  ≤ 1 13 (100)
  > 1 0 (0)
MMR mutational status, n (%)
 MSS 13 (100)
 MSI-H 0 (0)
Tumor histology type, n (%)
 Intestinal 10 (76.9)
 Mucinous 1 (7.7)
 Combined Mucinous and Intestinal 1 (7.7)
 Combined Signet ring cell and Intestinal 1 (7.7)
Tumor differentiation, n (%)
 Well 2 (15.3)
 Moderate 10 (77)
 Poorly 1 (7.7)
Median distance from anal verge, cm (range) 10 (3–14)
Clinical stage, n (%)
 TxN1 1 (7.7)
 T3N0 1 (7.7)
 T3N1 4 (30.8)
 T3N2 7 (53.8%)

ECOG, Eastern Cooperative Group Oncology Status; MMR, mismatch repair; MSI-H, microsatellite instability-high; MSS, microsatellite-stable